Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?
- PMID: 16263814
- PMCID: PMC3846532
- DOI: 10.1210/jc.2005-1804
Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?
Comment in
-
Commentary: Polycystic ovary syndrome--increased or preserved ovarian sensitivity to insulin?J Clin Endocrinol Metab. 2006 Aug;91(8):2859-60. doi: 10.1210/jc.2006-0317. Epub 2006 May 9. J Clin Endocrinol Metab. 2006. PMID: 16684824 No abstract available.
References
-
- Baillargeon JP, Iuorno MJ, Nestler JE. Insulin sensitizers for polycystic ovary syndrome. Clin Obstet Gynecol. 2003;46:325–340. - PubMed
-
- The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod. 2004;19:41–47. - PubMed
-
- Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83:2001–2005. - PubMed
-
- Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 1996;81:302–309. - PubMed
-
- Zhang G, Garmey JC, Veldhuis JD. Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17α-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells. Endocrinology. 2000;141:2735–2742. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
